Exchange: NASDAQ·Updated 07:55 PM EDT

TMDX News

News
all
press releases
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in TransMedics Group, Inc. (TransMedics or the Company) (NASDAQ: TMDX) for potential breaches of fiduciary duty on the part of its directors and...
Business Wire
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in TransMedics Group, Inc. (TransMedics or the Company) (NASDAQ: TMDX) for potential breaches of fiduciary duty on the part of its directors and...
Business Wire
More News
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR NewswireANDOVER, Mass., Oct. 30, 2026 ANDOVER, Mass., Oct. 30, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a...
PR Newswire
TransMedics to Present at Upcoming Investor Conferences
TransMedics to Present at Upcoming Investor Conferences TransMedics to Present at Upcoming Investor ConferencesPR NewswireANDOVER, Mass., Oct. 29, 2026 ANDOVER, Mass., Oct. 29, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is...
PR Newswire
TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026
TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026 TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026PR NewswireANDOVER, Mass., Oct. 22, 2026 ANDOVER, Mass., Oct. 22, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX...
PR Newswire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 26, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no costor...
PR Newswire
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook PR Newswire ANDOVER, Mass., Sept. 10, 2026 ANDOVER, Mass., Sept. 10, 2026 /PRNewswire...
PR Newswire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Sept. 7, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost...
PR Newswire
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks.
Zacks
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX PR Newswire NEW YORK, Aug...
PR Newswire

Advertisement|Remove ads.